Hood River Capital Management’s Evolent Health EVH Stock Holding History

Hood River Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,292,379	Closed	-$36.5M	–	166
2024 Q3	$36.5M	Sell	1,292,379 -325,073	-20%	-$8.38M	0.59%	65
2024 Q2	$30.9M	Sell	1,617,452 -589,585	-27%	-$15.1M	0.64%	58
2024 Q1	$72.4M	Buy	2,207,037 +137,004	+7%	+$4.37M	1.61%	16
2023 Q4	$68.4M	Buy	2,070,033 +162,421	+9%	+$4.6M	1.88%	13
2023 Q3	$51.9M	Buy	1,907,612 +1,063,363	+126%	+$29.6M	1.67%	16
2023 Q2	$25.6M	Buy	844,249 +10,448	+1%	+$338K	0.76%	56
2023 Q1	$27.1M	Buy	833,801 +35,301	+4%	+$1.12M	0.88%	48
2022 Q4	$22.4M	Buy	798,500 +228,906	+40%	+$6.56M	0.81%	50
2022 Q3	$20.5M	Buy	569,594 +20,798	+4%	+$733K	0.78%	48
2022 Q2	$16.9M	Buy	+548,796	New	+$16M	0.67%	58

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Hood River Capital Management's EVH Position: Q4 2024 in Review

Hood River Capital Management sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 1,292,379 shares — an estimated $36.5M sold.

Hood River Capital Management first reported a position in EVH in Q2 2022 and held it in 10 quarters. The position peaked at $72.4M in Q1 2024. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

Hood River Capital Management reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
Hood River Capital Management sold 1,292,379 Evolent Health shares in Q4 2024, an estimated $36.5M.
Hood River Capital Management first reported a position in Evolent Health in Q2 2022 and held it in 10 quarters.
Hood River Capital Management's Evolent Health position peaked at $72.4M in Q1 2024.
240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on Hood River Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.